ATE195522T1 - PYRAZOLO(4,3-C)PYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS SEROTONIN REUPtake INHIBITORS - Google Patents

PYRAZOLO(4,3-C)PYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS SEROTONIN REUPtake INHIBITORS

Info

Publication number
ATE195522T1
ATE195522T1 AT93116317T AT93116317T ATE195522T1 AT E195522 T1 ATE195522 T1 AT E195522T1 AT 93116317 T AT93116317 T AT 93116317T AT 93116317 T AT93116317 T AT 93116317T AT E195522 T1 ATE195522 T1 AT E195522T1
Authority
AT
Austria
Prior art keywords
loweralkyl
serotonin reuptake
reuptake inhibitors
chem
pyrazolo
Prior art date
Application number
AT93116317T
Other languages
German (de)
Inventor
Gregory Shutske
Kevin J Kapples
John Dick Tomer
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE195522T1 publication Critical patent/ATE195522T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)

Abstract

The invention relates to compounds of the frmula <CHEM> wherein Ar is <CHEM> or pyridyl; R1 is H,-(CH2)pNR2R3, <CHEM> R2 is hydrogen or loweralkyl; R3 is hydrogen or loweralkyl; R4 is hydrogen or loweralkyl; X and Y are independently halogen, trifluoromethyl, nitro, loweralkyl, loweralkoxy or hydroxy; n is 0, 1, 2 or 3; m is 0, 1 or 2; p and q are independently 2, 3 or 4; or a pharmaceutically acceptable addition salt and/or hydrate thereof, or where applicable, a geometric or optical isomer or racemic mixture thereof. This invention also relates to a process for making the compounds and to pharmaceutical compositions, and to their use as serotonin reuptake inhibitors.
AT93116317T 1992-10-22 1993-10-08 PYRAZOLO(4,3-C)PYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS SEROTONIN REUPtake INHIBITORS ATE195522T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/964,690 US5264576A (en) 1992-10-22 1992-10-22 Pyrazolo[4,3-c]pyridines which are intermediates

Publications (1)

Publication Number Publication Date
ATE195522T1 true ATE195522T1 (en) 2000-09-15

Family

ID=25508857

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93116317T ATE195522T1 (en) 1992-10-22 1993-10-08 PYRAZOLO(4,3-C)PYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS SEROTONIN REUPtake INHIBITORS

Country Status (18)

Country Link
US (4) US5264576A (en)
EP (1) EP0594001B1 (en)
JP (1) JP2656211B2 (en)
KR (1) KR100295026B1 (en)
CN (1) CN1049658C (en)
AT (1) ATE195522T1 (en)
AU (1) AU671305B2 (en)
CA (1) CA2108941A1 (en)
DE (1) DE69329231T2 (en)
DK (1) DK0594001T3 (en)
ES (1) ES2152237T3 (en)
FI (1) FI103890B1 (en)
GR (1) GR3034819T3 (en)
MX (1) MX9306552A (en)
NO (1) NO300374B1 (en)
NZ (1) NZ250003A (en)
PT (1) PT594001E (en)
TW (1) TW252114B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300498A (en) * 1993-06-04 1994-04-05 Hoechst-Roussel Pharmaceuticals Incorporated 6-piperazinyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acids, esters, amides and related compounds
US5618824A (en) * 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
US5565413A (en) * 1994-12-06 1996-10-15 Zeneca Limited Substituted pyridyl phenyl ketone herbicides
WO2002014315A2 (en) 2000-08-14 2002-02-21 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles
US20070117785A1 (en) * 2000-08-14 2007-05-24 Butler Christopher R Substituted pyrazoles and methods of treatment with substituted pyrazoles
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
CN1329392C (en) 2000-08-14 2007-08-01 奥索-麦克尼尔药品公司 Substituted pyrazoles
US20050101587A9 (en) * 2000-08-14 2005-05-12 Butler Christopher R. Method for treating allergies using substituted pyrazoles
DK1309592T3 (en) * 2000-08-14 2006-08-21 Ortho Mcneil Pharm Inc Substituted pyrazoles
US6369032B1 (en) 2000-09-06 2002-04-09 Ortho-Mcneil Pharmaceutical, Inc. Method for treating allergies
CA2482838A1 (en) 2002-05-31 2003-12-11 Eisai Co., Ltd. Pyrazole compounds and pharmaceutical compositions containing the compound
WO2010031791A1 (en) * 2008-09-16 2010-03-25 Biovitrum Ab (Publ) New compounds ii
CN102558174B (en) * 2011-08-23 2014-03-19 天津市斯芬克司药物研发有限公司 New pyrazolo[4,3-c]pyridine compound and synthesis method thereof
BR112014029674A2 (en) 2012-06-27 2017-06-27 Hoffmann La Roche compound, pharmaceutical composition, method for treating a disease, use of a compound, kit for treating a pim kinase-mediated condition and invention

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994890A (en) * 1974-01-31 1976-11-30 Chugai Seiyaku Kabushiki Kaisha 1-Aminoalkyl, 3-phenyl indazoles
JPS5944314B2 (en) * 1975-01-15 1984-10-29 中外製薬株式会社 Manufacturing method of indazole derivatives
JPS5936627B2 (en) * 1975-07-25 1984-09-05 中外製薬株式会社 Production method of indazole derivatives
DK27383A (en) * 1982-02-17 1983-08-18 Lepetit Spa PROCEDURE FOR PREPARING PYRAZOLE (4,3-C) PYRIDINES
JPH0615542B2 (en) * 1986-07-22 1994-03-02 吉富製薬株式会社 Pyrazolopyridine compound
EP0338087A4 (en) * 1987-10-13 1991-07-24 Yoshitomi Pharmaceutical Industries, Ltd. Fused pyrazole compounds, process for their preparation, and their medicinal use
DK181190D0 (en) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-ARYL-INDOL OR 3-ARYL-INDAZOL DERIVATIVES
EP0494774A1 (en) * 1991-01-11 1992-07-15 MERCK SHARP &amp; DOHME LTD. Indazole-substituted fivemembered heteroaromatic compounds
GB9216783D0 (en) * 1992-08-07 1992-09-23 Ici Plc Heterocyclic derivatives
US5300478A (en) * 1993-01-28 1994-04-05 Zeneca Limited Substituted fused pyrazolo compounds

Also Published As

Publication number Publication date
DE69329231D1 (en) 2000-09-21
JP2656211B2 (en) 1997-09-24
EP0594001A1 (en) 1994-04-27
US5380847A (en) 1995-01-10
NO933784D0 (en) 1993-10-21
JPH06192257A (en) 1994-07-12
KR940009185A (en) 1994-05-20
TW252114B (en) 1995-07-21
AU671305B2 (en) 1996-08-22
NZ250003A (en) 1996-03-26
PT594001E (en) 2001-01-31
CN1099033A (en) 1995-02-22
US5264576A (en) 1993-11-23
US5428169A (en) 1995-06-27
GR3034819T3 (en) 2001-02-28
CN1049658C (en) 2000-02-23
DE69329231T2 (en) 2001-03-29
FI934621A (en) 1994-04-23
KR100295026B1 (en) 2001-09-17
MX9306552A (en) 1994-06-30
US5296491A (en) 1994-03-22
NO933784L (en) 1994-04-25
FI103890B (en) 1999-10-15
NO300374B1 (en) 1997-05-20
FI103890B1 (en) 1999-10-15
EP0594001B1 (en) 2000-08-16
ES2152237T3 (en) 2001-02-01
FI934621A0 (en) 1993-10-20
CA2108941A1 (en) 1994-04-23
AU4912893A (en) 1994-05-05
DK0594001T3 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
ATE195522T1 (en) PYRAZOLO(4,3-C)PYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS SEROTONIN REUPtake INHIBITORS
ATE163012T1 (en) N-SUBSTITUTED 4-PYRIMIDINAMINES AND - PYRIMIDINDIAMINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
ATE143020T1 (en) AMINOCARBONYL CARBAMATES RELATED TO PHYSOSTIGMINE, METHOD FOR THEIR PRODUCTION AND THEIR USE AS A MEDICINAL PRODUCT
ATE211474T1 (en) GALANTHAMIN DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICATIONS
ATE140006T1 (en) 1-(PYRIDO(3,4-B&gt;-1,4-OXAZINYL-4-YL)-1H-INDOLES, INTERMEDIATE PRODUCTS AND A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
DE68902386D1 (en) N-PYRIDINYL-9H-CARBAZOL-9-AMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS.
ATE111899T1 (en) 1,2,3,4-TETRAHYDRO-1,9-ACRIDINEDIAMINE, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS MEDICATIONS.
ATE270287T1 (en) 2,3-DIHYDRO-1H-ISOINDOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS SEROTONIN REUPPOST INHIBITORS
ATE123493T1 (en) 3-(1H-INDAZOL-3-YL)-4-PYRIDINE NAME, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS.
ATE183746T1 (en) PYRIDO(3,4-B&gt;PYRROLO(1,2-E&gt;(1,4,5&gt;OXADIAZEPINES AND RELATED ANALOGUES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
DK164057C (en) OE5,6AA-CIS-1,3-OXATE HANDIDATE DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH DERIVATIVE
ATE151422T1 (en) 8-AZABICYCLO(3.2.1&gt;OCTYLALKYLTHIAZOLIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
DE3671017D1 (en) BENZO (C) -1,5-NAPHTHYRIDINE, A METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.
CA2052424A1 (en) 2-(4-piperidinyl)-1h-pyrido¬4,3-b|indol-1-ones and related compounds, intermediates and a process for their preparation
AU8608891A (en) 4-{4- or 6-(trifluoromethyl-2-pyridinyl)}-1-piperazinyl- alkyl substituted lactams
ATE122047T1 (en) 4,5,5A,6-TETRAHYDRO-3H-ISOXYZOLO(5,4,3-K1)ACRIDINE DERIVATIVES, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS MEDICATIONS.
GR3019469T3 (en) 2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments
DE69608030D1 (en) Process for the preparation of 2-naphthamide derivatives, and intermediates for the production of 2-naphthamide derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee